Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
How would you approach a localized but unresectable adenoid cystic carcinoma of the distal trachea?
Answer from: Radiation Oncologist at Academic Institution
Curative intent RT
Comments
Radiation Oncologist at University of Cincinnati Cancer Center
Can you describe your treatment volumes?
11395
Sign In
or
Register
to read more
17928
Related Questions
Would you consider omitting concurrent chemoradiation for a patient with stage III EGFR-mutant NSCLC and initiating treatment with osimertinib instead?
Would you offer SBRT for primary pulmonary adenoid cystic carcinoma in a patient who was medically not a surgical candidate?
Would the presence of an SVC stent affect your decision to offer BID vs once-daily chemoradiation for SCLC?
How do you talk with your patients regarding radiographic expectations on surveillance CT after lung SBRT?
In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?
Is there a role for the addition of radiation to preoperative chemoimmunotherapy in NSCLC with limited N2 disease planned for surgery?
What target expansions do you use when treating with 60 Gy in 15 fractions for the lung?
Would you treat a patient with an N2 ipsilateral recurrence following re-resection of bronchial stump recurrence?
Would you give durvalumab consolidation to a patient with stage III NSCLC with an STK11 mutation?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
Can you describe your treatment volumes?